Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Biomarker Identification a Challenge and Opportunity in Cancer Drug Development, Survey Finds
This news piece from Precision Medicine Online provides an overview of the findings from ICON’s recent survey of professionals engaged in oncology-related clinical research. It shares respondents' insights on how precision medicine approaches are changing development strategies and the to the extent these therapeutic advances will benefit patients in the future.
-
Validating COAs: Key steps for accurate and reliable clinical trial data
With the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in recent decades.
-
Ensuring data integrity and quality in clinical research outcomes
In this interview with Asia Business Outlook Magazine, Nagalakshmi Shetty, Vice President & India Country Head shares how changes in data management have changed the way clinical research is practiced and emphasises the role of interdisciplinary collaborations in progressing research.
-
Us and it
This article by Gerard Quinn, Vice President of IT Innovation and Informatics, which appeared in PharmaTimes Magazine, delves into how AI is transforming clinical trials by improving efficiency, accelerating timelines, and enhancing decisions across the clinical development process.
-
Streamlining bioprocesses with automation
In this article from BioPharm International, Ronan Fox, Senior Vice President, IT R&D, provides commentary on the evolving role of automation in biopharmaceutical development.
-
DCT Tracker: Charting the next chapter for decentralisation
More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.
-
Liver disease, obesity and the value of treatment
This article by Dr Alan Baldridge and Jolanta M. Wichary, discusses the link between obesity and metabolic-dysfunction associated steatotic liver disease (MASLD), and touches on recent advancements in effective treatments for obesity.
-
ACRO Good Clinical Podcast: Paediatric clinical trials: Compassion in action
Jacqui Whiteway, Senior Director & Paediatric Strategy Liaison, Centre for Paediatric Clinical Development at ICON participates in this discussion on what makes paediatric clinical trials unique and how the industry can make participation easier for paediatric patients and their families.
-
Symphony Health RWD utilized to determine prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease
Real world data from Symphony Health, an ICON plc company, was used in this retrospective, observational study on prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease. These results may help healthcare providers to determine the underlying risk of tendon injuries and guide treatment of this patient population.
-
Engaging minority communities: collaborative practises and long-term success
Rare diseases can disproportionately affect minorities, yet these communities are often underrepresented in clinical studies. ICON’s experts suggest ways to improve engagement and diversity.
